ATE365035T1 - Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks - Google Patents
Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticksInfo
- Publication number
- ATE365035T1 ATE365035T1 AT02784195T AT02784195T ATE365035T1 AT E365035 T1 ATE365035 T1 AT E365035T1 AT 02784195 T AT02784195 T AT 02784195T AT 02784195 T AT02784195 T AT 02784195T AT E365035 T1 ATE365035 T1 AT E365035T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitors
- reuppost
- norepinephrine
- treat
- tics
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33449401P | 2001-11-30 | 2001-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE365035T1 true ATE365035T1 (de) | 2007-07-15 |
Family
ID=23307469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02784195T ATE365035T1 (de) | 2001-11-30 | 2002-11-12 | Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20050014843A1 (de) |
| EP (1) | EP1455770B1 (de) |
| JP (1) | JP2005515199A (de) |
| KR (1) | KR20050044604A (de) |
| AT (1) | ATE365035T1 (de) |
| AU (1) | AU2002347984A1 (de) |
| CA (1) | CA2466649A1 (de) |
| DE (1) | DE60220825T2 (de) |
| DK (1) | DK1455770T3 (de) |
| ES (1) | ES2287338T3 (de) |
| PT (1) | PT1455770E (de) |
| WO (1) | WO2003047560A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6602911B2 (en) | 2001-11-05 | 2003-08-05 | Cypress Bioscience, Inc. | Methods of treating fibromyalgia |
| EP1482921A1 (de) * | 2002-02-12 | 2004-12-08 | Cypress Bioscience, Inc. | Verfahren zur behandlung von aufmerksamkeitsdefizit/hyperaktivitätsstörungen (adhd) |
| JP2007513945A (ja) * | 2003-12-12 | 2007-05-31 | イーライ リリー アンド カンパニー | 体熱感、衝動調節障害および一般的な病状による人格変化の治療 |
| WO2006077846A1 (ja) * | 2005-01-18 | 2006-07-27 | Mitsubishi Pharma Corporation | 注意欠陥/多動性障害治療薬 |
| US7994220B2 (en) * | 2005-09-28 | 2011-08-09 | Cypress Bioscience, Inc. | Milnacipran for the long-term treatment of fibromyalgia syndrome |
| US20080031932A1 (en) * | 2006-08-04 | 2008-02-07 | Watson Laboratories, Inc. | Transdermal atomoxetine formulations and associated methods |
| KR102096165B1 (ko) | 2018-05-03 | 2020-04-01 | 노충구 | 틱 장애 개선 및 치료 효과를 가지는 약학적 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4314081A (en) * | 1974-01-10 | 1982-02-02 | Eli Lilly And Company | Arloxyphenylpropylamines |
| IL56369A (en) * | 1978-01-20 | 1984-05-31 | Erba Farmitalia | Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them |
| US5281624A (en) * | 1991-09-27 | 1994-01-25 | Eli Lilly And Company | N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof |
| US6323242B1 (en) * | 1998-12-02 | 2001-11-27 | Peter Sterling Mueller | Treatment of disorders secondary to organic impairments |
| ATE305307T1 (de) * | 1999-07-01 | 2005-10-15 | Pharmacia & Upjohn Co Llc | Reboxetin zur behandlung von migränekopfschmerzen |
| CN1396829A (zh) * | 2000-02-24 | 2003-02-12 | 法玛西雅厄普约翰美国公司 | 新的药物联合形式 |
| AU2002232470B2 (en) * | 2001-01-02 | 2005-11-03 | Pharmacia & Upjohn Company Llc | New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
-
2002
- 2002-11-12 WO PCT/US2002/033628 patent/WO2003047560A1/en active IP Right Grant
- 2002-11-12 US US10/495,303 patent/US20050014843A1/en not_active Abandoned
- 2002-11-12 JP JP2003548816A patent/JP2005515199A/ja active Pending
- 2002-11-12 PT PT02784195T patent/PT1455770E/pt unknown
- 2002-11-12 EP EP02784195A patent/EP1455770B1/de not_active Expired - Lifetime
- 2002-11-12 CA CA002466649A patent/CA2466649A1/en not_active Abandoned
- 2002-11-12 AU AU2002347984A patent/AU2002347984A1/en not_active Abandoned
- 2002-11-12 DE DE60220825T patent/DE60220825T2/de not_active Expired - Fee Related
- 2002-11-12 ES ES02784195T patent/ES2287338T3/es not_active Expired - Lifetime
- 2002-11-12 AT AT02784195T patent/ATE365035T1/de not_active IP Right Cessation
- 2002-11-12 DK DK02784195T patent/DK1455770T3/da active
- 2002-11-12 KR KR1020047008010A patent/KR20050044604A/ko not_active Application Discontinuation
-
2008
- 2008-04-01 US US12/060,318 patent/US20080200555A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005515199A (ja) | 2005-05-26 |
| DK1455770T3 (da) | 2007-10-08 |
| EP1455770A1 (de) | 2004-09-15 |
| DE60220825D1 (de) | 2007-08-02 |
| PT1455770E (pt) | 2007-09-06 |
| DE60220825T2 (de) | 2008-03-06 |
| US20080200555A1 (en) | 2008-08-21 |
| WO2003047560A1 (en) | 2003-06-12 |
| EP1455770B1 (de) | 2007-06-20 |
| KR20050044604A (ko) | 2005-05-12 |
| ES2287338T3 (es) | 2007-12-16 |
| CA2466649A1 (en) | 2003-06-12 |
| AU2002347984A1 (en) | 2003-06-17 |
| US20050014843A1 (en) | 2005-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE452642T1 (de) | Verwendung von cox-2 inhibitoren zur behandlung von affectiven störungen | |
| DE602004017736D1 (de) | Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust | |
| ATE241358T1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
| DK1809280T3 (da) | Mitotiske kinesininhibitorer og fremgangsmåder til anvendelse deraf | |
| ATE473753T1 (de) | Verwendung von botulinum toxin zur behandlung von post-operative schmerzen | |
| ATE322258T1 (de) | Methoden und zusammensetzungen zur modulation der aktivität der alpha-adrenergen rezeptoren | |
| DE602004014117D1 (de) | Thiazole zur verwendung als inhibitoren von protein-kinasen | |
| DK1651161T3 (da) | Farmaceutiske præparater og fremgangsmåder til at fremme sårheling | |
| MY169308A (en) | Treatment of tnf? related disorders | |
| CR7807A (es) | Piperacinil y diacepanil benzamidas y benztioamidas | |
| DK1315506T3 (da) | Phospholipidderivater af valproinsyre og blandinger deraf | |
| ATE260653T1 (de) | Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen | |
| DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
| NO20025405D0 (no) | Modulatorer for TNF-alfa-signalisering | |
| ATE365035T1 (de) | Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks | |
| ATE353667T1 (de) | Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges | |
| ATE402699T1 (de) | Verwendung von substituierten pyrazolen zur behandlung von allergien | |
| ATE359283T1 (de) | Substituierte pyrazinonverbindungen zur behandlung von entzündungen | |
| DE60329326D1 (de) | Tace inhibitoren | |
| MY136367A (en) | Treatment of cognitive failure | |
| EA200200948A1 (ru) | Лечение псориаза | |
| ATE536874T1 (de) | Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen | |
| ATE317261T1 (de) | Verwendung von mirtazapin zur behandlung von schlafstörungen | |
| CY1110156T1 (el) | Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης | |
| ATE404203T1 (de) | Verwendung von desoxypeganin zur behandlung der klinischen depression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1455770 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |